Cite
HARVARD Citation
Cardenas, M. et al. (n.d.). CP-061 Long-term cost-effectiveness analysis of infliximab, etanercept and adalimumab in rheumatoid arthritis patients in real-life clinical practice. European journal of hospital pharmacy. p. A24. [Online].